Both in Pharmaceuticals
Aktis Oncology vs Collegium Pharmaceutical
Over the past year AKTS returned −32.1% and COLL returned −48.0%; their daily moves had a correlation of 0.03.
AKTS −32.1% COLL −48.0%Growth of $1, one year, split-adjusted
| Metric | AKTS | COLL |
|---|---|---|
| Price | $15.20 | $23.67 |
| Market cap | $845.4M | $770.6M |
| Today | +1.74% | −0.25% |
| 1 month | −14.9% | +8.2% |
| 6 months | −24.1% | −35.2% |
| Year to date | — | −48.9% |
| 1 year | — | −34.4% |
| Revenue growth (YoY) | — | +6.3% |
| Gross margin | 100.0% | 86.7% |
| Net margin | −713.5% | −7.5% |
| P/E (TTM) | — | 16.1× |
| Price / sales | — | 1.0× |
| Net cash | $517.3M | -$962.1M |
| Dividend yield | — | — |
| Volatility (60d) | 55.2% | 33.9% |
| Short % of float | 18.3% | 17.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).